Avana

Avana

Dosage
50mg 100mg 200mg
Package
12 pill 24 pill 36 pill 60 pill 88 pill 120 pill
Total price: 0.0
  • In the United Kingdom and other authorised markets avana (marketed as Spedra®/Stendra®) is a prescription-only medicine and should be supplied from a pharmacy on presentation of a valid prescription; although some online vendors or pharmacies may claim to sell it without a prescription, this is not legal or recommended.
  • Avana is used to treat erectile dysfunction; it is a phosphodiesterase type‑5 (PDE5) inhibitor that increases cGMP levels in penile tissue, causing smooth‑muscle relaxation and increased blood flow to produce an erection.
  • The usual dose is 100 mg taken before sexual activity; other available strengths are 50 mg (often used for special populations or to assess tolerability) and 200 mg (only if lower doses are ineffective); do not take more than one dose in 24 hours.
  • Administered orally as film‑coated tablets (typical pack sizes in foil blisters: 50 mg, 100 mg, 200 mg).
  • Onset of action can be as fast as 15 minutes, with many patients experiencing effects within 15–30 minutes.
  • The duration of action is typically up to about 6 hours, though individual response may vary.
  • Avoid excessive alcohol intake; alcohol can worsen dizziness and low blood pressure and may reduce the effectiveness of the medicine.
  • The most common side effect is headache (other common effects include flushing, nasal congestion, back pain and dizziness).
  • Would you like to try avana without a prescription?
Trackable delivery 5-9 days
Payment method Visa, Mastercard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Avana Information

  • INN (International Nonproprietary Name): Avanafil
  • Brand Names Available In United Kingdom: Spedra — foil blister tablets in 50 mg, 100 mg and 200 mg strengths
  • ATC Code: G04BE11
  • Forms & Dosages: Oral tablets 50 mg, 100 mg, 200 mg; no topical or parenteral forms specified
  • Manufacturers In United Kingdom: Menarini Group (European licence and distribution); Vivus Inc. is the Stendra licence holder internationally
  • Registration Status In United Kingdom: Spedra is listed as marketed in the United Kingdom (European/centralised authorisation through EMA since 2013)
  • OTC / Rx Classification: Prescription only (Rx)

Latest Research Highlights

What Does Recent Research Tell Men Looking For A Fast-Acting Option?

Randomised trials and real‑world cohorts across the UK and EU published between 2022 and 2025 continue to place avanafil in a clear clinical niche as a rapid‑onset PDE5 inhibitor.

Median time‑to‑efficacy in several on‑demand studies is commonly reported around 15 minutes, supporting its role for men who value spontaneity.

Head‑to‑head and network meta‑analyses show comparable improvements in erectile function scores such as IIEF‑EF when avanafil is compared with sildenafil and vardenafil.

Post‑marketing safety surveillance and periodic regulatory reports from marketing authorisation holders and the EMA list common adverse events as headache, flushing and nasal congestion.

Serious events remain uncommon when contraindications are respected, and reviews note lower rates of visual disturbances with avanafil, consistent with reduced PDE6 cross‑reactivity.

Key regulatory milestones remain the FDA approval as Stendra in 2012 and EMA authorisation as Spedra in 2013.

Marketed strengths in the UK are Spedra 50 mg, 100 mg and 200 mg tablets.

Major limitations highlighted across reviews include generally shorter follow‑up in many trials, limited data in severe hepatic or renal impairment, and scant published evidence in men over 75 years.

Quick Comparative Trial Table

Trial Population Design Primary Endpoint Onset Time Major AE Rate
Representative RCT Men With ED Randomised, double‑blind IIEF‑EF Change ≈15 minutes Headache, flushing, nasal congestion
Head‑to‑Head Comparison Men With ED Comparative RCT / network meta Sexual Encounter Success Avanafil ≈15 min; Sildenafil longer Similar efficacy; fewer visual AEs with avanafil
Post‑Marketing Cohort Real‑World Clinics (EU) Multicentre observational Patient‑Reported Outcomes Median ≈15 min Low rate serious events when contraindications avoided

Clinical Effectiveness In The UK

Who Benefits Most According To NHS Outcomes And Patient Feedback?

Audits from NHS and private urology clinics plus patient‑reported outcome studies indicate Spedra performs well where rapid onset is a priority.

Many UK men report quicker readiness for intercourse compared with their prior experience on sildenafil or tadalafil.

NHS clinicians typically prescribe avanafil on an on‑demand basis, with 100 mg commonly advised about 15 minutes before activity and dose adjusted to 50 mg or 200 mg according to tolerability and response.

Community pharmacists in Boots, LloydsPharmacy and Superdrug often counsel patients on safe use, interactions and timing.

Electronic Prescription Service (EPS) is commonly used in primary care and facilitates collection at community pharmacies.

Local NHS formularies vary, and many trusts prefer sildenafil or tadalafil first‑line because of cost and longer experience.

Patient experience highlights the value of pharmacist counselling, discreet online clinic services and clear advice about nitrates and cardiac risk.

IIEF / EHS Improvements: Real World Versus RCTs

Setting Reported Improvement
UK Real‑World Cohorts Clinically meaningful gains in IIEF and EHS; rapid onset noted
Randomised Controlled Trials Comparable IIEF improvements vs sildenafil/vardenafil

Indications And Expanded Uses

What Is Licensed And What Might Specialists Try Off‑Label?

Licensed Indication
Avanafil (Spedra) is authorised for the treatment of erectile dysfunction in men.
Common Off‑Label Uses
Use Under Specialist Supervision For Post‑Radical Prostatectomy Erectile Dysfunction — Evidence Level: limited; specialist clinics may trial avanafil when first‑line PDE5 inhibitors fail.
Occasional Private Clinic Trials In Complex ED Cases — Evidence Level: low to moderate real‑world data only.

MHRA and EMA product literature confirm there is no licensed indication for women and that daily prophylactic dosing is not authorised.

Off‑label prescribing should be documented with informed consent and typically remains specialist‑led rather than routine NHS practice.

Cardiovascular assessment is emphasised before initiation for any licensed or off‑label use.

Composition And Brand Landscape In The UK

What Will You Find In The Packet?

Brand Manufacturer / Licence Dosages Packaging
Spedra Menarini Group (EU/UK distribution) 50 mg, 100 mg, 200 mg Foil blister tablets
Stendra Vivus Inc. (international trade name in US/Canada) 50 mg, 100 mg, 200 mg Foil blister tablets

Avanafil is classified under ATC code G04BE11 as a PDE5 inhibitor used in genito‑urinary therapy.

There are no topical or injectable preparations specified in major markets.

No widely available generics in the EU/UK are reported as of August 2025.

Store Spedra tablets at room temperature, ideally 20–25°C, with permitted excursions 15–30°C, and check batch and expiry before supply.

Contraindications And Special Precautions

Who Must Not Take Spedra And Who Needs Extra Care?

  • Absolute Contraindications: concurrent nitrates, guanylate cyclase stimulators (for example riociguat), known hypersensitivity to avanafil or excipients, severe cardiovascular instability (recent MI or stroke, unstable angina), and severe hepatic impairment.
  • Relative Cautions: anatomical penile deformity such as Peyronie’s disease; conditions predisposing to priapism (sickle cell disease, leukaemia); severe renal impairment; poorly controlled blood pressure; and hereditary retinal disorders such as retinitis pigmentosa.

Prescribers should screen cardiovascular risk and reconcile concurrent medicines at the GP or community pharmacy before initiation.

The MHRA Yellow Card scheme is central to reporting unexpected serious adverse events or suspected interactions.

Checklist For Prescribers

  • Confirm absence of nitrates and riociguat in current medication list.
  • Assess recent cardiac events or unstable angina.
  • Consider lower starting dose in hepatic impairment or interacting drugs.
  • Document consent for any off‑label use.

Who Needs Cardiology Review?

Scenario Action
Recent Coronary Event (MI within months) Cardiology review before prescribing
Unstable Arrhythmia Specialist assessment recommended

Dosage Guidelines

How Should Patients Be Advised To Use Spedra?

  1. Start with 100 mg taken approximately 15 minutes before anticipated sexual activity.
  2. Reduce to 50 mg if tolerability problems occur or certain interacting drugs are present; consider increasing to 200 mg only after clinical reassessment if lower doses are ineffective.
  3. Do not take more than one dose in 24 hours.
  4. Try several attempts at the chosen dose before deeming treatment ineffective.

Elderly patients do not require routine dose reduction but use clinical judgement.

Mild or moderate renal impairment usually requires no change, while severe renal impairment is a reason for caution because data are limited.

For hepatic impairment, use a lower dose for mild/moderate disease and avoid use in severe hepatic impairment.

Drug And Food Interactions

Which Medicines And Foods Affect Avanafil?

Drug Class Interaction Clinical Action
Nitrates Severe hypotension if combined Absolute contraindication — do not co‑prescribe
Guanylate Cyclase Stimulators (e.g. riociguat) Risk of marked hypotension Do not co‑prescribe
Potent CYP3A4 Inhibitors (some azoles, macrolides, HIV protease inhibitors) Increased avanafil exposure Consider dose reduction and increased monitoring
Alpha‑Blockers Additive hypotension Start at low dose; counsel on orthostatic precautions
Grapefruit / Grapefruit Juice May increase plasma levels Avoid significant intake

Pharmacists should report suspected serious or unexpected reactions via the MHRA Yellow Card service to support UK pharmacovigilance.

Cultural Perceptions, Patient Habits And Help-Seeking In The UK

How Do Men In The UK Approach Erectile Dysfunction Treatment?

Many men value discretion, safety and convenience when seeking treatment for ED.

GPs remain the common first contact, but online private clinics and NHS 111 routes are increasingly used for faster access.

Patient forums such as Patient.info commonly stress trust in pharmacists, clear cardiovascular screening and practical advice on timing.

Younger men often prefer rapid‑onset options like avanafil for spontaneity, while older men commonly choose sildenafil or tadalafil because of familiarity and formulary availability.

Community pharmacies provide face‑to‑face counselling, and registered online pharmacies must perform remote clinical checks before supply.

Clinicians should tackle stigma directly, invite partner‑inclusive conversations when appropriate, and signpost reliable NHS patient portals for further reading.

Availability, Prescribing Routes And Pricing Patterns

Where Can Patients Obtain Spedra And How Much Will It Cost?

Spedra is prescription‑only and available in the UK as 50 mg, 100 mg and 200 mg blister tablets via community pharmacies and licensed online providers.

Prescribers include GPs, urology clinics and private clinics, with electronic prescriptions commonly used for pharmacy collection.

Prescription charges differ across the UK: England retains the standard prescription fee per item unless a patient is exempt.

Scotland, Wales and Northern Ireland do not have routine prescription charges for patients, creating regional cost differences.

Private purchase prices vary between chains and online clinics, and consultation fees may be bundled with medication costs.

Registered online sellers must comply with MHRA and GPhC requirements and patients should avoid grey‑market imports.

In our online pharmacy, avana is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Supply Routes And Cost Factors

Supply Route Typical Cost Factors
NHS Prescription Prescription fee (England) or no fee (Scotland/Wales/N.I.); formulary decisions influence availability
Private Clinic Consultation fee plus medication cost; possible rapid access
Online Pharmacy Variable pricing; ensure MHRA/GPhC registration

Comparable Medicines And Prescribing Preferences

How Does Avanafil Compare With Other PDE5 Inhibitors?

  • Sildenafil (Viagra/generics): longer time to onset and well‑established; widely available and often first‑line on NHS formularies.
  • Tadalafil (Cialis): longest half‑life and licensed for daily use; favoured when duration or daily dosing is desired.
  • Vardenafil (Levitra): similar onset to sildenafil with somewhat higher rates of visual disturbance in some reports.

Avanafil offers a faster onset (around 15 minutes) and lower PDE6 cross‑reactivity, which translates into fewer visual side‑effects for some patients.

NHS practice commonly favours sildenafil or tadalafil as first‑line because of cost and longstanding formulary use, and avanafil is often considered when rapid onset or previous adverse effects justify a switch.

Prescriber Decision Checklist

  1. Record prior PDE5 inhibitor use and response.
  2. Assess cardiac risk and current medications for interactions.
  3. Discuss timing preference, side‑effect profile and cost with the patient.
  4. Consider avanafil where rapid onset is desired or where visual AEs occurred on other agents.

FAQ

  1. How Quickly Does Spedra Work And When Should I Take It?

    Start with 100 mg about 15 minutes before sexual activity.

    Some patients use 50 mg or 200 mg depending on tolerability and effect.

  2. Can I Take Avanafil With My Heart Tablets?

    Do not take avanafil with nitrates or riociguat.

    Other cardiac medicines need review by your GP or pharmacist before starting.

  3. Will It Affect Fertility Or Protect Against STIs?

    Avanafil does not affect fertility and does not prevent sexually transmitted infections.

  4. Can I Buy It Online Without A Prescription?

    Prescription is required for lawful supply in the UK, although some online services perform remote clinical checks prior to supply.

    Always use MHRA/GPhC‑registered online pharmacies or NHS pathways to avoid counterfeit products.

For serious adverse events, patients and clinicians are encouraged to use the Yellow Card scheme to report reactions.

Practical Guidance For Proper Use And Pharmacist Counselling

What Should Pharmacists Say During Counselling?

Verify the prescription and allergy history before supply.

Review current medicines for nitrates, alpha‑blockers and potent CYP3A4 inhibitors.

Advise on timing: typically 100 mg about 15 minutes before activity, with adjustment to 50 mg or 200 mg as clinically appropriate.

Emphasise one dose per 24 hours and the on‑demand nature of therapy rather than daily prophylaxis.

Advise that alcohol can increase dizziness and blunt response, and caution about driving the first few times if dizziness occurs.

Explain signs of serious adverse events such as priapism (erection lasting more than four hours), sudden vision or hearing loss and severe hypotension, and provide clear actions such as seeking immediate A&E care for priapism.

Record counselling in pharmacy records and encourage Yellow Card reporting for unexpected serious reactions.

Offer patient information leaflets and signpost NHS.uk or local urology services for ongoing support.

Short Counselling Script For Pharmacy Use

  • Confirm the dose and explain timing (100 mg ≈15 minutes before activity).
  • Ask about nitrates, riociguat, and potent antifungals or antibiotics.
  • Advise on side‑effects and when to seek urgent medical help.
  • Document the consultation and supply appropriate written information.

Delivery Across United Kingdom

City Region Delivery Time
London England 5-7 days
Birmingham England 5-7 days
Manchester England 5-7 days
Glasgow Scotland 5-7 days
Leeds England 5-7 days
Liverpool England 5-7 days
Bristol England 5-7 days
Edinburgh Scotland 5-7 days
Cardiff Wales 5-7 days
Belfast Northern Ireland 5-7 days
Newcastle Upon Tyne England 5-9 days
Nottingham England 5-9 days
Sheffield England 5-9 days

Final Practical Notes

Avanafil, marketed as Spedra in the UK, is a useful option where rapid onset and a favourable visual side‑effect profile are priorities.

Ensure a clear cardiovascular assessment and medication reconciliation before prescribing or supply.

Encourage patients to trial different doses across several attempts before concluding lack of effect.

Direct patients to reliable NHS resources and advise reporting of serious or unexpected reactions via Yellow Card.

Pharmacists should keep records of counselling and monitor for interactions, particularly with nitrates and potent CYP3A4 inhibitors.